IN8bio Inc. (INAB)
IN8bio Statistics
Share Statistics
IN8bio has 81.26M shares outstanding. The number of shares has increased by 84.16% in one year.
| Shares Outstanding | 81.26M |
| Shares Change (YoY) | 84.16% |
| Shares Change (QoQ) | 12.11% |
| Owned by Institutions (%) | 63.46% |
| Shares Floating | 64.72M |
| Failed to Deliver (FTD) Shares | 13.52K |
| FTD / Avg. Volume | 0.25% |
Short Selling Information
The latest short interest is 1M, so 1.38% of the outstanding shares have been sold short.
| Short Interest | 1M |
| Short % of Shares Out | 1.38% |
| Short % of Float | 1.74% |
| Short Ratio (days to cover) | 0.51 |
Valuation Ratios
The PE ratio is -0.45 and the forward PE ratio is -0.93. IN8bio's PEG ratio is 0.01.
| PE Ratio | -0.45 |
| Forward PE | -0.93 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 0.95 |
| P/FCF Ratio | -0.57 |
| PEG Ratio | 0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for IN8bio.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.08, with a Debt / Equity ratio of 0.35.
| Current Ratio | 4.08 |
| Quick Ratio | 4.08 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | -0.17 |
| Debt / FCF | -0.21 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1.69M |
| Employee Count | 18 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -86.36% in the last 52 weeks. The beta is 0.23, so IN8bio's price volatility has been higher than the market average.
| Beta | 0.23 |
| 52-Week Price Change | -86.36% |
| 50-Day Moving Average | 0.24 |
| 200-Day Moving Average | 0.39 |
| Relative Strength Index (RSI) | 25.64 |
| Average Volume (20 Days) | 5.41M |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -30.44M |
| Net Income | -30.44M |
| EBITDA | -30.44M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.57 |
Balance Sheet
The company has 11.12M in cash and 5.03M in debt, giving a net cash position of 6.09M.
| Cash & Cash Equivalents | 11.12M |
| Total Debt | 5.03M |
| Net Cash | 6.09M |
| Retained Earnings | -121.66M |
| Total Assets | 20.94M |
| Working Capital | 9.49M |
Cash Flow
In the last 12 months, operating cash flow was -24.15M and capital expenditures -104K, giving a free cash flow of -24.25M.
| Operating Cash Flow | -24.15M |
| Capital Expenditures | -104K |
| Free Cash Flow | -24.25M |
| FCF Per Share | -0.45 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INAB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for INAB is $3.6, which is 2300% higher than the current price. The consensus rating is "Buy".
| Price Target | $3.6 |
| Price Target Difference | 2300% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Scores
| Altman Z-Score | -11.1 |
| Piotroski F-Score | 1 |